HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.
HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.